Dana-farber Cancer Institute

This study tests whether a blood test that detects HPV DNA can help doctors choose the right level of treatment for people with HPV-positive throat cancer. About 116 participants with early-stage cancer will receive therapy tailored to their risk, aiming to improve survival and r…

This study is for adolescents and young adults (ages not specified) newly diagnosed with Philadelphia chromosome-negative acute lymphoblastic leukemia (ALL). Researchers are testing a chemotherapy regimen that includes the immunotherapy drug blinatumomab along with several standa…

This study looks at a blood test called the GRAIL Galleri test that may find many types of cancer early. Researchers will enroll 100 adults with signs of cancer to see how well the test works compared to usual methods. The goal is to understand if this test can help detect cancer…

This study compares two low-dose hormone drugs, exemestane and tamoxifen, in 140 post-menopausal women at high risk for breast cancer. The goal is to see which drug causes fewer menopausal side effects while still helping to prevent breast cancer. Participants will take the medic…

This study tests whether adding acupuncture to virtual exercise can reduce nerve pain caused by a common bladder cancer drug combination. About 50 adults with advanced bladder cancer will be split into two groups: one gets acupuncture plus virtual exercise, the other gets virtual…

This study tests an educational program called SHARE-MC designed to help women with metastatic breast cancer address sexual health concerns. About 96 women who are bothered by sexual problems will take part. The program aims to improve sexual function and reduce emotional distres…

This study is testing a smartphone app called I-STAMP that helps people with advanced cancer manage their pain and keep track of their medications. About 73 adults with advanced cancer and pain will try the app and give feedback on how easy it is to use and how helpful it feels. …

This study is testing a mobile app called my.naviGATE for teens and young adults (ages 15-24) who have finished cancer treatment. The app provides personalized education, peer support, and tracks how patients are doing. Researchers want to see if the app helps patients feel more …